Home » Newsletters » BioWorld Science

BioWorld Science

April 8, 2021

View Archived Issues

Bayer initiates phase II study of runcaciguat in nonproliferative diabetic retinopathy

Boehringer Ingelheim starts enrolling participants in phase I study of BI-1323495

VB-85247, a member of a novel class of macrocyclic STING agonists

Brain metastases of breast cancer depend on fatty acid synthesis

FDA clears IND for phase II study of MIT-001 as therapy of CCRT-induced oral mucositis in HNSCC

Enrollment begins in phase III study of futibatinib in CCA harboring FGFR2 gene rearrangements

First patient dosed in phase II AFFINITY basket study of atrasentan

Biotest adds additional patient group to ongoing phase III AdFIrst study of BT-524

Alkermes collaborates with MSD to evaluate nemvaleukin alfa in combination with Keytruda

Shionogi and Hsiri Therapeutics patent compounds for mycobacterial infections

X-Chem discloses new HAOX1 inhibitors

Terns identifies thyroid hormone receptor beta agonists

Vincere Biosciences presents new USP30 inhibitors

First cohort fully enrolled in WWRD Study of AVM-0703

Cell Biotech divulges vector constructs for colon cancer

Trodelvy granted expanded approval by FDA for metastatic TNBC

Phenex Pharmaceuticals develops novel class of heme-displacing IDO-1 inhibitors

Subcutaneous injection of Tysabri approved in Europe for relapsing-remitting MS

Enrollment ongoing in phase II study of IC-14 chimeric antibody in patients with COVID-19

Calico and AbbVie initiate first-in-human study of ABBV-CLS-484

RMC-5552 enters phase I development for relapsed/refractory solid tumors

SMN gene therapy can result in too much of a good thing

Patient recruitment ongoing in phase III study of Tookad VTP in upper tract urothelial carcinoma

Stearoyl-CoA-desaturase inhibitor YTX-7739 shows efficacy in glioblastoma mouse models

NIH initiates study to assess allergic reactions to Moderna and Pfizer-BioNTech COVID-19 vaccines

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...